|
Drugs: endocrine system
Citations 1-10 of 20 total displayed.
|
Most recent content
(17 Feb 2009):
|
- Commentary
Insulin analogues: too much noise about small benefits
- Andrea Siebenhofer-Kroitzsch, MD, Karl Horvath, MD, and Johannes Plank, MD
Can. Med. Assoc. J. 2009; 180: 369-370.
[Full text]
[PDF]
- Research
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis
- Sumeet R. Singh, BScPhm MSc, Fida Ahmad, MSc, Avtar Lal, MD PhD, Changhua Yu, MD MSc, Zemin Bai, MD MSc, and Heather Bennett, BPharm PhD
Can. Med. Assoc. J. 2009; 180: 385-397.
[Abstract]
[Full text]
[PDF]
[ Résumé ] [ Online Appendices ]
|
Past content
(since Sep 1999):
|
- Practice
Management of hypothyroidism during pregnancy
- Tammy J. Bungard and Mary Hurlburt
Can. Med. Assoc. J. 2007; 176: 1077-1078.
[Full text]
[PDF]
- Letters
Effect of thiazolidinediones on lipid profile
- Alice Y.Y. Cheng and I. George Fantus
Can. Med. Assoc. J. 2005; 173: 344-a-345-a.
[Full text]
[PDF]
- Letters
Effect of thiazolidinediones on lipid profile
- Pankaj Madan
Can. Med. Assoc. J. 2005; 173: 344.
[Full text]
[PDF]
- Review
Oral antihyperglycemic therapy for type 2 diabetes mellitus
- Alice Y.Y. Cheng and I. George Fantus
Can. Med. Assoc. J. 2005; 172: 213-226.
[Abstract]
[Full text]
[PDF]
- Letters
Mercenary hypocrisy at CMAJ
- John Hoey
Can. Med. Assoc. J. 2004; 170: 174-b.
[Full text]
[PDF]
- Synopsis
Is there sustained renal benefit from previous intensive insulin therapy in people with type 1 diabetes?
- Steven L. Shumak
Can. Med. Assoc. J. 2004; 170: 40-41.
[Full text]
[PDF]
- Review
Diagnosis and management of hyperprolactinemia
- Omar Serri, Constance L. Chik, Ehud Ur, and Shereen Ezzat
Can. Med. Assoc. J. 2003; 169: 575-581.
[Abstract]
[Full text]
[PDF]
- Practice
Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure
- Eric Wooltorton
Can. Med. Assoc. J. 2002; 166: 219.
[Full text]
[PDF]
|
|
